Mirror Biologics, Inc. Employee Directory
Biotechnology ResearchFlorida, United States11-50 Employees
Mirror Biologics is a biopharmaceutical company focused on developing off-the-shelf, non-genetically manipulated living immune cell therapies for metastatic solid tumors and as a universal vaccine against respiratory viral infections in the elderly. It operates across multiple sites, including Tampa, Florida; Jerusalem, Israel; Bangkok, Thailand; and Kuala Lumpur, Malaysia, supporting manufacturing, bioreactor research, clinical immunology analysis, and related operations. The lead therapy, AlloStim, is an allogeneic living immune cell product derived from donor precursor cells and formulated with monoclonal antibody-coated microparticles to induce patient-specific immune responses without prior knowledge of the disease. The company is developing high-volume artificial lymph node bioreactors to scale up production and frozen dosage forms to extend shelf life and distribution efficiency. Mirror Biologics holds exclusive worldwide rights to AlloStim and the Mirror Effect technology platform, acquired from Immunovative Therapies. In 2024, the company announced the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer and Vice President of Corporate Development.
1-888-653-2347 
support@leadiq.com 
